Literature DB >> 29726384

Body-mass index and metastatic melanoma outcomes.

Hannah Lennon1, Ellena Badrick2, Matthew Sperrin3, Andrew G Renehan4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29726384     DOI： 10.1016/S1470-2045(18)30277-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.

Authors:  Mei Jiang; Aline F Fares; Daniel Shepshelovich; Ping Yang; David Christiani; Jie Zhang; Kouya Shiraishi; Brid M Ryan; Chu Chen; Ann G Schwartz; Adonina Tardon; Sanjay Shete; Matthew B Schabath; M Dawn Teare; Loic Le Marchand; Zuo-Feng Zhang; John K Field; Hermann Brenner; Nancy Diao; Juntao Xie; Takashi Kohno; Curtis C Harris; Angela S Wenzlaff; Guillermo Fernandez-Tardon; Yuanqing Ye; Fiona Taylor; Lynne R Wilkens; Michael Davies; Yi Liu; Matt J Barnett; Gary E Goodman; Hal Morgenstern; Bernd Holleczek; Sera Thomas; M Catherine Brown; Rayjean J Hung; Wei Xu; Geoffrey Liu
Journal:  Lung Cancer       Date:  2020-12-04       Impact factor: 5.705

2.  The influence of body mass index on the survival of patients with melanoma. A cross-sectional study of 707 patients.

Authors:  Cesar Zepeda-Najar; Leonardo Saul Lino-Silva; Jazmin D Chávez-Hernandez; Rosa A Salcedo-Hernández; Johana P Jimenez-Sánchez; Carlos E Fernández-Sánchez; Carlos D Valdez-Aguilar
Journal:  Contemp Oncol (Pozn)       Date:  2021-03-24

3.  Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study.

Authors:  Ji Hyun Lee; Sujin Hyung; Jeeyun Lee; Sang-Hee Choi
Journal:  J Immunother Cancer       Date:  2022-08       Impact factor: 12.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.